234 related articles for article (PubMed ID: 10599535)
1. Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction.
Holper EM; Giugliano RP; Antman EM
Coron Artery Dis; 1999 Dec; 10(8):567-73. PubMed ID: 10599535
[TBL] [Abstract][Full Text] [Related]
2. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
3. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
Campbell KR; Ohman EM; Cantor W; Lincoff AM
Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.
Di Pasquale P; Cannizzaro S; Scalzo S; Maringhini G; Vitrano GM; Giubilato A; Giambanco F; Sarullo FM; Paterna S
Int J Cardiol; 2003 Dec; 92(2-3):265-70. PubMed ID: 14659863
[TBL] [Abstract][Full Text] [Related]
5. Role of glycoprotein IIb/IIIa-receptor inhibitors in managing ST-segment-elevation myocardial infarction.
Racine E
Am J Health Syst Pharm; 2002 Nov; 59(21 Suppl 7):S27-36. PubMed ID: 12434712
[TBL] [Abstract][Full Text] [Related]
6. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
Montalescot G; Borentain M; Payot L; Collet JP; Thomas D
JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.
Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN
Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986
[TBL] [Abstract][Full Text] [Related]
8. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition.
Califf RM
Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314
[TBL] [Abstract][Full Text] [Related]
10. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
[TBL] [Abstract][Full Text] [Related]
11. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
Silva MA; Donovan JL; Gandhi PJ; Volturo GA
Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
[TBL] [Abstract][Full Text] [Related]
12. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Marino P
Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
[TBL] [Abstract][Full Text] [Related]
13. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
De Luca G; Savonitto S; van't Hof AW; Suryapranata H
Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis.
Cannon CP
Clin Cardiol; 1999 Aug; 22(8 Suppl):IV37-43. PubMed ID: 10492852
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction.
Vivekananthan DP; Patel VB; Moliterno DJ
J Interv Cardiol; 2002 Apr; 15(2):131-9. PubMed ID: 12063808
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction.
Eisenberg MJ; Jamal S
J Am Coll Cardiol; 2003 Jul; 42(1):1-6. PubMed ID: 12849651
[TBL] [Abstract][Full Text] [Related]
17. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
Ohman EM; Kleiman NS; Gacioch G; Worley SJ; Navetta FI; Talley JD; Anderson HV; Ellis SG; Cohen MD; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt MM; Sigmon KN; Califf RM; Krucoff MW; Topol EJ
Circulation; 1997 Feb; 95(4):846-54. PubMed ID: 9054741
[TBL] [Abstract][Full Text] [Related]
18. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Adgey AA
Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
[TBL] [Abstract][Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
Boersma E; Akkerhuis KM; Théroux P; Califf RM; Topol EJ; Simoons ML
Circulation; 1999 Nov; 100(20):2045-8. PubMed ID: 10562258
[TBL] [Abstract][Full Text] [Related]
20. The role of eptifibatide in patients undergoing percutaneous coronary intervention.
Zeymer U
Expert Opin Pharmacother; 2007 Jun; 8(8):1147-54. PubMed ID: 17516878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
